To compared outcomes of regional nerve blocks with those of standard analgesics after hip fracture. DESIGN: Multisite randomized controlled trial from April 2009 to March 2013. SETTING: Three New York hospitals. PARTICIPANTS: Individuals with hip fracture (N = 161). INTERVENTION: Participants were randomized to receive an ultrasound-guided, single-injection, femoral nerve block administered by emergency physicians at emergency department (ED) admission followed by placement of a continuous fascia iliaca block by anesthesiologists within 24 hours (n = 79) or conventional analgesics (n = 82). MEASUREMENTS: Pain (0-10 scale), distance walked on Postoperative Day (POD) 3, walking ability 6 weeks after discharge, opioid side effects. RESULTS: Pain scores 2 hours after ED presentation favored the intervention group over controls (3.5 vs 5.3, P = .002). Pain scores on POD 3 were significantly better for the intervention than the control group for pain at rest (2.9 vs 3.8, P = .005), with transfers out of bed (4.7 vs 5.9, P = .005), and with walking (4.1 vs 4.8, P = .002). Intervention participants walked significantly further than controls in 2 minutes on POD 3 (170.6 feet, 95% confidence interval (CI) = 109.3-232 vs 100.0 feet, 95% CI = 65.1-134.9; P = .04). At 6 weeks, intervention participants reported better walking and stair climbing ability (mean Functional Independence Measure locomotion score of 10.3 (95% CI = 9.6-11.0) vs 9.1 (95% CI = 8.2-10.0), P = .04). Intervention participants were significantly less likely to report opioid side effects (3% vs 12.4%, P = .03) and required 33% to 40% fewer parenteral morphine sulfate equivalents. CONCLUSION: Femoral nerve blocks performed by emergency physicians followed by continuous fascia iliaca blocks placed by anesthesiologists are feasible and result in superior outcomes.
studies have shown that hip fracture pain has been associated with greater risk of postoperative complications [5] [6] [7] and leads to prolonged bed rest, delayed ambulation, missed or shortened physical therapy sessions, and impaired function postoperatively and for as long as 6 months after surgery. 5 Although opioids are an effective treatment for pain, they are problematic in older adults because of their side effect profile. 8, 9 Because of their potential to reduce opioid side effects, regional anesthesia techniques are attractive alternatives in older adults with fracture pain. Two recent systematic reviews have highlighted the benefits of perioperative nerve blocks over standard care (oral and parenteral analgesics) in reducing hip fracture pain, and the American Academy of Orthopedic Surgeons recently issued a strong recommendation to employ these techniques in the management of this condition. 10, 11 Nevertheless, the integration of these techniques into routine care has been problematic. A comprehensive review of the management of pain in hip fracture noted that, although "nerve blockade is within the repertoire of most practicing anesthesiologists, many clinicians do not perform it routinely because they believe the additional time, effort, and supervision required may outweigh the benefits." 11 The effects of blockades on ambulation or rehabilitation, outcomes beyond the perioperative period, and systemic opioid use are also unclear.
Ideally, effective pain management for hip fracture should begin at presentation to the ED and be seamlessly integrated into routine medical and surgical care. Results that demonstrated that femoral nerve blocks administered under ultrasound guidance can be taught to emergency physicians (EP) 12 and that they can administer them safely and that a mobile peripheral nerve block service can be seamlessly integrated into routine preoperative hip fracture care 13 have been previously reported. Herein, the main outcomes of a randomized controlled trial that compared a pain management program consisting of a single-injection femoral nerve block (FNB) administered by an EP followed by placement of a continuous fascia iliaca block (cFIB) by an anesthesiologist 24 hours later with conventional analgesic treatment (opioids and acetaminophen administered at treating physician discretion) at three New York hospitals are reported. Outcomes included ED pain, pain and function postoperatively and 6 weeks after discharge, and opioid requirements and side effect incidence.
METHODS

Study Design
This was a randomized controlled trial to compare peripheral nerve blocks with conventional analgesic therapy in individuals with hip fracture aged 60 and older presenting to three New York EDs on outcomes of pain, functional recovery, and analgesic side effects. The study hospitals included a 1,171 bed quaternary care academic medical center (Mount Sinai) and an 856-bed academic teaching hospital (Beth Israel), both located in Manhattan, and a 711-bed teaching hospital in Brooklyn (Maimonides Medical Center). Maimonides was added as a third site midway through the study (October 2011) because of declining hip fracture admissions at Beth Israel. After training sessions for EPs at the three study sites in the utility and performance of FNBs (described elsewhere 12 ), eligible and consenting individuals with hip fracture presenting to study hospitals were randomized to receive FNB (intervention) or standard therapy (control) in the ED. An anesthesiologist subsequently placed a cFIB in intervention participants within 24 hours after the initial single injection FNB on the orthopedic ward or in the operating room at the time of surgery-whichever occurred sooner. This mobile peripheral nerve block service has been previously described. 13 Control participants received conventional standing and as-needed parenteral or oral analgesics (opioids and acetaminophen) as determined by the treating physicians. Evidence and expert guidance available at the time of the study did not support the use of nerve blocks over conventional analgesics, and standard practice in the study institutions did not include regional nerve blocks for hip fracture analgesia.
Subjects were interviewed daily about pain and opioid-related side effects, had physical performance testing conducted on postoperative day (POD) 3, and were interviewed over the telephone 6 weeks after discharge to assess walking ability. The institutional review boards of the three participating hospitals approved the study.
Participants
Trained clinical interviewers prospectively screened all individuals admitted to the three EDs daily from 8:00 a.m. to 8:00 p.m., Sunday to Friday, April 2009 through March 2013. The screening window was based on admission data that suggested that 80% of individuals with hip fracture would be captured during this time period. Individuals were eligible for inclusion if they were aged 60 and older with a radiographically confirmed hip fracture (femoral neck, intertrochanteric, pericapsular). Exclusion criteria are detailed in Figure 1 . All participants gave written consent.
Randomization and Masking
Subjects were randomized to FNB or standard care (control) using a computer-generated, stratified, blocked randomization list, with stratification according to site. The block size for the randomization was randomly chosen for each block as two, four, or six participants. After determining eligibility and obtaining informed consent at ED admission, the interviewers conducted an initial brief pain interview. After conducting the initial interview, interviewers informed the treating physician that the individual was enrolled in the trial, left the ED, and contacted the project manager (TF) to inform her of a study enrollee in the ED and the identity of the treating physician. The project manager determined randomization status by opening a sealed envelope and, remaining blinded to the individual's identity, contacted the treating EP to let them know whether their enrolled participant was to receive a FNB or standard analgesic care. Intervention participants were also able to receive as-needed opioids at the discretion of treating physicians. Interviewers remained blinded to participants' randomization status throughout the trial, as did the investigators.
Procedures
In July of each study year (October 2011 at Maimonides initially), all incoming EP residents at each site were trained in ultrasound-guided FNB. 12 A core group of teaching attending EPs was also trained at each site to ensure appropriate oversight. The single-shot FNB consisted of 20 mL of 0.5% bupivacaine and was performed under ultrasound guidance. Within 24 hours after the FNB or at the time of surgery, whichever was sooner, an anesthesiologist inserted a cFIB infusion catheter under ultrasound guidance. A bolus of 15 mL of 0.2% ropivacaine was injected, followed by a continuous infusion of 0.2% ropivacaine at 5 mL/h. Catheters were removed after POD 3.
Control participants received oral and intravenous analgesic therapy at the discretion of the treating physician. Sham saline injections and catheter infusions were considered but rejected as pilot data demonstrated that neither EPs nor anesthesiologists would perform sham injections because they believed them to be unethical. Sham catheters taped to the skin were initially employed as a blinding technique for the cFIB but were subsequently discarded early in the course of the study because clinical nursing staff were routinely able to detect the difference between sham and actual catheters. 
Included in final analyses (n=81)
Included in final analyses (n=72) Figure 1 . CONSORT Diagram. Enrollment statistics and intervention protocols. Individuals were eligible for inclusion if they were aged 60 and older with a radiographically confirmed hip fracture (femoral neck, intertrochanteric, or pericapsular). Individuals with multiple trauma, cancer-related fractures, bilateral hip fractures, or previous fracture or surgery at the currently fractured site and those who were transferred from another hospital; presented more than 48 hours after fracture; had a history of substance abuse as evidenced by an affirmative response to either of the first two items on the Drug Abuse Screening Test 14 or documentation of a history of substance abuse in the medical record; were delirious according to the Confusion Assessment Method (CAM); 15 did not speak English, Spanish, or Russian; had a history of an allergy or adverse reaction to bupivacaine or ropivacaine; had an allergy to opioid analgesics; had a bleeding diatheses; were unable to self-report their pain; or had moderate cognitive impairment as documented by a score of 3 or less on the Callahan six-item screener were excluded. 16 Details regarding the 1,004 excluded individuals are as follows: advanced dementia, n = 390, prior hip fracture, n = 86, presented after study hours, n = 102, younger than 60, n = 168, language barrier, n = 72, pathologic fracture, n = 68, more than 48 hours at home before presenting to emergency department (ED), n = 45, decision for nonsurgical management, n = 9, bilateral fracture, n = 17, substance abuse, n = 15, transferred from another hospital, n = 12. After enrollment, subjects were randomized to femoral nerve block (FNB) or conventional care using a stratified blocked randomization list with stratification according to site. The block size for the randomization was randomly chosen for each block as 2, 4, or 6 participants.
Immediately after obtaining informed consent at ED admission, interviewers queried eligible individuals about their pain. Enrolled participants were asked to rate their pain from 0 to 10 on a numeric rating scale (NRS), with 0 being no pain and 10 the worst pain imaginable. Subjects were also queried as to their current pain level (0-10 NRS) and pain relief (worse pain than prior pain, no relief, slight relief, moderate relief, a lot of relief, complete relief) 1 and 2 hours after enrollment.
Participants were interviewed daily (Sunday-Friday) and asked to rate their pain from 0 to 10 at rest, with transfer out of bed, and with walking past a bedside chair. Interviewers assessed opioid side effects 14 and delirium daily using the Confusion Assessment Method supplemented by chart review. 7 If participants could not be interviewed on a particular day (e.g., Saturdays or because they were unavailable and off the floor), they were asked on the following day to rate their present pain level and their pain on the prior missed day. On POD 3, participants cleared for weight bearing walked for 2 minutes under supervision of a physical therapist, and the distance walked was recorded. Participant characteristics were obtained from interviews and medical record review. Comorbid conditions were measured using the Charlson Comorbidity Index. 15 Functional status before fracture was measured using the motor subscales of the Functional Independence Measure (FIM), 16 depression using the 15-item Geriatric Depression Scale, 17 and overall healthrelated quality of life according to self-report as excellent, very good, good, fair, or poor. Participants were interviewed over the telephone 6 weeks after discharge about their functional status.
Outcomes
Main outcome measures included pain 1 and 2 hours after ED admission, at rest, with transfers out of bed, and with walking on POD 3 and distance walked in 2 minutes on POD 3. Secondary outcomes included opioid requirements (morphine sulfate equivalents) and opioid related side effects (≥1 days of severe nausea, sedation, or mental cloudiness), number of physical therapy sessions missed or shortened, and FIM locomotion scores (ability to walk and climb stairs) 6 weeks after discharge.
Statistical Analyses
The initial sample size projections targeted a total sample size of 396 subjects to provide 80% power to detect a 0.5-point difference in ED and postoperative pain scores using a two-sided a of .05 using standard deviations and means from prior publications. Midway through the planned participant enrollment, it became apparent that the rate of hip fractures had declined substantially at one of the study hospitals, and the study's Data Safety Monitoring Board (DSMB) recommended adding two additional study sites pending the results of a preplanned interim analysis. The interim analysis revealed a markedly greater effect size of the intervention on pain scores and function than hypothesized. As a result of these analyses, the DSMB advised a reduction in the targeted sample size to 150 participants and recommended adding only one additional siteMaimonides Medical Center. Differences between study groups in baseline characteristics and clinical outcomes were assessed using two-sided Fisher exact tests, chi-square tests for categorical variables, and independent-sample Student t-tests for continuous variables. All analyses were intention to treat and were performed using Stata version 13.1 (Stata Corp., College Station, TX). To reduce the possibility of an inflated Type 1 error due to multiple comparisons, P-values were adjusted (q) using the BenjaminiHochberg False Discovery Rate (FDR) procedure (q = .05). 18, 19 Multivariable analyses (not presented) controlling for age, prefracture functional status, prefracture pain level, type of fracture and repair, and preexisting comorbidity revealed similar results. Figure 1 (CON-SORT diagram) and participant characteristics in Table 1 . Analyzable data were available for 81 control (98% of enrolled subjects) and 72 intervention (91% of enrolled subjects) participants at hospital discharge and 57 (70%) control and 51 (71%) intervention participants 6 weeks after discharge. Eight intervention participants (11%) were transferred to the operating room before they could receive an ED FNB. Seven intervention participants (no overlap) had their cFIB catheter removed before POD 3 (2 at participant request, 3 became dislodged, 2 because nursing staff insisted they be removed because participants developed delirium that staff attributed to the catheters). There were no significant differences in baseline participant characteristics between the two groups and between participants who completed the study and those lost to followup.
RESULTS
Study enrollment details are shown in
There were no significant differences in baseline pain at ED admission. Intervention participants had significantly less pain than controls at 1 (3.7, 95% CI = 3.0-4.5 vs 5.3, 95% CI = 4.7-6.1, P = .001, q = .001) and 2 (3.5, 95% CI = 2.8-4.3 vs 5.3, 95% CI = 4.6-6.0, P < .001, q = .003) hours after ED admission (Figure 2 ). Pain scores on POD 3 also favored the intervention (Figure 3 ). Participants in the intervention arm had significantly less pain at rest (1.8, 95% CI = 0.9-1.9 vs 2.9, 95% CI = 2.3-3.6, P = .005, q = .013), with transfers (4.7, 95% CI = 4.1-5.3 vs 5.9, 95% CI = 5.2-6.6, P = .005, q = .013), and with walking (4.1, 95% CI = 3.5-4.8 vs 5.6, 95% CI = 4.8-6.4, P = .002, q = .008) than controls.
Function was better in intervention participants than controls. Intervention participants walked more than 70 feet farther in 2 minutes on POD 3 than controls (170.6 feet, 95% CI = 109.3, 232.0 vs 100.0 feet, 95% CI = 65.1-134.9, P = .04, q = .048). Intervention participants were significantly more likely than controls to report that they were walking beyond a bedside chair by POD 3 (82% vs 64% respectively, odds ratio (OR) = 2.49, 95% CI 1.17-5.29, P = .02, q = .039) and significantly less likely to have a physical therapy session missed or shortened (12.5% vs 27.2%, OR = 0.38, 95% CI = 0.16-89, P = .03, q = .048). At 6 weeks, intervention participants reported better walking and stair climbing ability (mean FIM locomotion score 10.3, 95% CI = 9.6-11.0 vs 9.1, 95% CI = 8.2, 10.0, P = .04, q = .049).
Intervention participants required 33% fewer parenteral morphine sulfate equivalents than controls in the ED (0.8 mg/h, 95% CI = 0.64-1.05 mg/h vs 1.2 mg/h, 95% CI = 0.94-1.40 mg/h, P = .03, q = .048). For the first 3 postoperative days, control participants received an average of 3.5 mg/d (95% CI = 2.46-4.48) of parenteral morphine sulfate equivalents, compared with 2.1 mg/d (95% CI = 1.16-2.95) for intervention participants (P = .04, q = .048). The number of participants reporting a severe opioid-related side effect (≥1 days of severe nausea, sedation, or unclear thinking) was significantly lower in the intervention group than controls (3.0% vs 12.4%, OR = 0.20, 95% CI = 0.04-0.96, P = .04, q = .048). There were no episodes of bleeding, falls, or catheterrelated infections in the intervention group, and delirium rates were similar in both groups (17.1% control, 15.9% intervention, P = .83).
CONCLUSIONS
These results suggest that an interdisciplinary, regional anesthesia-based nerve block program for individuals with acute hip fracture involving early single-shot FNBs performed by EPs followed by cFIBs performed by anesthesiologists is feasible and results in better analgesic and functional outcomes than conventional oral and parenteral analgesic therapy. Participants randomized to the intervention reported lower pain scores after ED admission, and this improvement persisted through POD 3. Intervention participants were also observed to have enhanced walking ability postoperatively and at 6 weeks after hospital discharge and lower opioid requirements. Whereas untreated pain has been shown to be associated with greater suffering and other adverse outcomes in hip fracture, 7, 20 its treatment remains problematic.
11,21
Scheduled opioid therapy, although shown to be effective in improving pain and other outcomes, 14 is difficult to manage and is associated with challenging side effects in older adults. Peripheral nerve blocks performed by anesthesiologists have been shown to result in better pain management than standard analgesic therapy (acetaminophen with opioids). 11 Despite recent guidelines recommending their use, 10 regional nerve blocks have yet to become the standard of care in the management of hip fracture pain-largely because of logistical difficulties in getting anesthesiologists to the ED and because of beliefs that the additional time and effort outweigh the block's benefits.
This study adds to the existing literature described above in several important ways and presents novel findings. First, it replicates the results of prior single-site and single-operator studies that have demonstrated better analgesia associated with regional nerve blocks than with oral and parenteral analgesic therapies. 10, 11 As importantly, this is the first multicenter trial to the knowledge of the authors that demonstrates that regional nerve blocks can result in better ambulation after hip fracture than traditional analgesic treatments. 10 The difference in FIM locomotion scale score represents the difference of being able to walk 150 feet and less than 50 feet without human assistance. In real-life terms, this may represent the difference between being confined at home versus having the ability to ambulate for reasonable distances outside the home.
Second, this interdisciplinary analgesic program of a single FNB placed immediately upon fracture diagnosis in the ED followed by a cFIB results in significantly better pain control, lower rates of opioid-related side effects, and lower opioid requirements than conventional analgesic therapy within 1 hour of presentation through POD 3. This study builds upon prior research by extending the period of analgesia over that of studies that have employed only single blocks (in the ED or immediately before surgery) [22] [23] [24] [25] [26] and by providing analgesia immediately after presentation to the ED versus studies that used continuous blocks at the time of surgery. 27 Third, previous work 22 has been extended by demonstrating that EPs can be trained effectively in ultrasound-guided FNB 12 and that this procedure can be performed safely and efficaciously in three diverse EDs, ensuring immediate and effective relief for hip fracture-related pain. Finally, it was demonstrated that anesthesiologists can easily integrate placement of cFIB into preoperative hip fracture care using a mobile block service. 13 In both settings-the ED and perioperative medical and surgical floors-blocks are well tolerated and do not appear to interfere with surgical repair, postoperative recovery, physical therapy, or postoperative ambulation, nor are they associated with increased rates of complications.
There are several limitations to this study. Participants did not receive sham nerve blocks, and it is possible that some of the observed results may have resulted from a placebo effect. Sham blocks were considered but rejected because of ethical concerns of subjecting people to unnecessary pain and because the EP clinical partners refused to administer sham injections. The control group consisted of individuals receiving usual pain care, and consistent with previous studies, 5, 14, 28 pain management practice at all study sites was not reflective of expert guideline recommendations in terms of opioid dosing, use of regularly scheduled analgesics, and management of opioid side effects. Whereas one could argue that the provision of guideline-appropriate opioid therapy might mitigate the differences in outcomes observed, two decades of research and quality improvement programs have failed to ensure that individuals in pain receive adequate opioid therapy. 29 Although the cFIBs were well tolerated, 10% of intervention participants requested that the catheter be discontinued or had the catheter become dislodged and elected not to have it reinserted. Enrollment was limited to a specific population of individuals with hip fracture, and as such, the results may not generalize to the hip fracture population as a whole. For example, only individuals who were able to self-report their pain were enrolled, and data were not available on individuals with advanced dementia. Given known disparities in treatment of pain in individuals with dementia, 30 they may benefit even more from these procedures than these study subjects. Other groups excluded were those taking anticoagulants or platelet inhibitors and those who did not speak English, Spanish, or Russian. It was also not possible to evaluate the maintenance of FNB skill of EPs for longer than 1 year. Nevertheless, ultrasound-guided procedures (vascular access, paracentesis, lumbar puncture, other regional blocks) have become well integrated into EM practice and are now considered fundamental components of emergency medicine. 31 Finally, 29% of the sample could not be contacted at 6 weeks, and it is possible that the improvements in function observed in the intervention group might not have persisted at this point had the full sample been available for analyses. Prior studies, albeit observational and nonrandomized clinical trials, have shown similar improvements in postdischarge function associated with better pain management. 5, 14 In summary, this randomized controlled trial of regional nerve blocks and catheters to control hip fracture pain beginning at ED admission had important and novel findings. It is the largest and most rigorously designed study of the use of regional nerve blocks in this condition in older adults and provides the first randomized controlled trial data showing that reducing perioperative pain improves functional outcomes. This research, combined with prior smaller, single-site studies, supports the integration of regional nerve blocks into the routine care of individuals with hip fracture commencing with their presentation to the ED.
